Patent foramen ovale and stroke: Should PFOs be closed in otherwise cryptogenic stroke?
Since initial reports of its association with ischemic stroke appeared in 1988, there has been continued controversy regarding the existence and strength of the association between patent foramen ovale (PFO) and ischemic stroke. Many case-control studies have reported an association between incident cryptogenic ischemic stroke and PFO, yet population-based studies have failed to confirm this association. Studies of the risk of recurrent stroke in patients with cryptogenic stroke with or without PFO have not shown an increased risk of recurrent stroke in patients with PFO. Meanwhile, use of devices to close PFOs and atrial septal defects percutaneously has increased dramatically since their introduction. Completion of the randomized clinical trials of PFO closure currently in progress is vital to determine if the benefits of PFO closure in cryptogenic stroke outweigh its risks.
Carpenter
David A
DA
Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA. carpenterd@wustl.edu
Ford
Andria L
AL
Lee
Jin-Moo
JM
D002986:Clinical Trials as Topic; D054092:Foramen Ovale, Patent / Q000150:complications* / Q000175:diagnosis / Q000628:therapy*; D006344:Heart Septal Defects, Atrial; D006801:Humans; D012307:Risk Factors; D020521:Stroke / Q000209:etiology*; D019851:Thrombophilia / Q000150:complications; D020246:Venous Thrombosis / Q000150:complications
Am J Cardiol. 1997 Oct 15;80(8):1066-9
9352979
J Am Coll Cardiol. 2006 Jan 17;47(2):440-5
16412874
Ann Thorac Surg. 2008 Nov;86(5):1584-90; discussion 1590-1
19049754
J Negat Results Biomed. 2008 Oct 13;7:7
18851751
Can J Cardiol. 1999 Jan;15(1):57-64
10024860
Circulation. 2008 Nov 4;118(19):1999-2004
18981314
J Am Coll Cardiol. 2005 Feb 1;45(3):377-80
15680715
Stroke. 2008 Dec;39(12):3131-6
18818401
Semin Thromb Hemost. 2009 Jul;35(5):505-14
19739041
Thromb Haemost. 2009 May;101(5):813-7
19404532
Circulation. 2002 Jun 4;105(22):2625-31
12045168
Stroke. 2004 Jan;35(1):46-50
14657451
Stroke. 2000 Oct;31(10):2407-13
11022072
N Engl J Med. 2001 Apr 19;344(16):1222-31
11309638
Neurology. 1996 May;46(5):1301-5
8628471
Circulation. 1995 Jun 1;91(11):2785-92
7758185
N Engl J Med. 2001 Dec 13;345(24):1740-6
11742048
Thromb Haemost. 2009 Dec;102(6):1280-2
19967163
N Engl J Med. 1988 May 5;318(18):1148-52
3362165
Stroke. 2000 May;31(5):1062-8
10797166
Am J Cardiol. 2005 Oct 1;96(7):1007-10
16188533
Lancet. 1988 Jul 2;2(8601):11-2
2898621
Neurology. 2000 Oct 24;55(8):1172-9
11071496
Stroke. 2001 Dec 1;32(12):2735-40
11739965
J Am Coll Cardiol. 2007 Feb 20;49(7):797-802
17306710
Int J Cardiol. 2005 May 11;101(1):77-82
15860387
J Am Coll Cardiol. 2004 Aug 18;44(4):750-8
15312853
Circulation. 2009 Nov 3;120(18):1837-41
19884482
Ann Intern Med. 2003 Nov 4;139(9):753-60
14597460
Mayo Clin Proc. 1984 Jan;59(1):17-20
6694427
Circulation. 2001 Apr 10;103(14):1928
11294814
Ann Intern Med. 1993 Sep 15;119(6):461-5
8357111
Am J Cardiol. 1996 Jun 1;77(14):1202-9
8651096
Curr Opin Cardiol. 2008 Nov;23(6):537-44
18830067
Stroke. 2009 Jul;40(7):2337-42
19498198
Am Heart J. 1995 Nov;130(5):1083-8
7484740
Circulation. 2009 May 26;119(20):2743-7
19433754
Mayo Clin Proc. 2006 May;81(5):602-8
16706256
J Am Coll Cardiol. 2004 Jan 21;43(2):302-9
14736453
Stroke. 1993 Jan;24(1):31-4
8418547